<DOC>
	<DOC>NCT01833585</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of G-CSF-mobilized autologous peripheral blood mononuclear cell injection to ischemic limbs of patients with critical limb ischemia.</brief_summary>
	<brief_title>Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<criteria>Patients with critical limb ischemia confirmed by toe pressure, ABI, TCOM Levels of arterial occlusion are femoropopliteal or tibioperoneal occlusion Poor distal artery runoff Age 1870 year Planned for major amputation within 4 weeks Receive blood component within 4 weeks Acute myocardial infarction severe valvular heart disease renal failure liver failure Cancer Hypercoagulable state Severe infection Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>ischemic ulcer</keyword>
	<keyword>rest pain</keyword>
	<keyword>gangrene</keyword>
</DOC>